Enalapril Export Market Intelligence: India's 261 Suppliers Shipping to 115 Countries — TransData Nexus 2026

Q: Who are the top enalapril exporters from India?

The top enalapril exporters from India are: 1. MYLAN LABORATORIES LIMITED — $197.1M (83.8% market share); 2. IPCA LABORATORIES LIMITED — $6.8M (2.9% market share); 3. J B CHEMICALS AND PHARMACEUTICALS LIMITED — $4.8M (2.0% market share); 4. AUROBINDO PHARMA LTD — $4.0M (1.7% market share); 5. WEXFORD LABORATORIES PRIVATE LIMITED — $2.5M (1.1% market share). Together they account for 91.5% of India's total enalapril export value.

Q: What is the total export value of enalapril from India?

The total export value of enalapril from India is $235.3M USD, recorded across 3,403 shipment transactions from 261 active exporters to 115 destination countries. The average shipment value is $69.1K.

Q: Which countries import enalapril from India?

India exports enalapril to 115 countries worldwide. The top importing countries are: HUNGARY (83.4% share, $196.1M), SOUTH AFRICA (4.2% share, $10.0M), MALTA (1.8% share, $4.1M), CROATIA (1.4% share, $3.3M), ECUADOR (1.0% share, $2.4M). These five markets account for 91.8% of total export value.

Q: What is the HS code for enalapril exports from India?

The primary HS code for enalapril exports from India is 30049071. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of enalapril exports from India?

The average unit price for enalapril exports from India is $5.32 USD per unit, with prices ranging from $0.00 to $1024.25 depending on formulation, packaging, and order volume. The total market is valued at $235.3M across 3,403 shipments.

Q: Which ports handle enalapril exports from India?

The primary ports for enalapril exports from India are NHAVA SHEVA SEA (INNSA1) (13.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (10.0% of shipments), SAHAR AIR (7.5% of shipments), JNPT/ NHAVA SHEVA SEA (6.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (6.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of enalapril?

India is one of the world's leading exporters of enalapril due to its large base of 261 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports enalapril to 115 countries, demonstrating 59% global market coverage.

Q: What certifications do Indian enalapril exporters need?

Indian enalapril exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import enalapril from India?

There are 583 registered buyers importing enalapril from India, spread across 115 countries. The repeat buyer rate is 64.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top enalapril supplier from India?

MYLAN LABORATORIES LIMITED is the leading enalapril exporter from India with a market share of 83.8% and total export value of $197.1M across 91 shipments. The top 5 suppliers together control 91.5% of total export value.

Suresh Sormare

Enalapril

India Pharmaceutical Trade Intelligence

$235.3M261 Suppliers115 CountriesHS 30049071

ExportsIndia → HUNGARY83.4%India → SOUTH AFRICA4.2%

ImportsMALTA → India$658.8K UNITED STATES → India$80.8K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Enalapril Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Enalapril to the World

Between 2022 and 2026, India exported $235.3M worth of enalapril across 3,403 verified shipments to 115 countries — covering 59% of world markets in the Cardiovascular segment. The largest destination is HUNGARY (83.4%). MYLAN LABORATORIES LIMITED leads with a 83.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·HS 30049071

Enalapril export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Enalapril export data snapshot — $235.3M · 261 exporters · 115 countriesTransData Nexus · Indian Customs Data

Top Enalapril Exporters from India

261 active exporters · Ranked by export value

View all 261 →

Top Enalapril Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$197.1M	91	4	83.8%
2	IPCA LABORATORIES LIMITED

Top Countries Importing Enalapril from India

115 destination markets · Ranked by import value

All 115 countries →

Top Countries Importing Enalapril from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	HUNGARY	$196.1M	83.4%
2	SOUTH AFRICA	$10.0M	4.2%
3	MALTA	$4.1M	1.8%
4	CROATIA	$3.3M	1.4%
5	ECUADOR	$2.4M	1.0%
6	UNITED STATES	$2.4M	1.0%
7	NETHERLANDS	$2.1M	0.9%
8	FINLAND	$1.8M	0.8%
9	CHILE	$1.4M	0.6%
10	ANGOLA	$1.3M	0.6%

HUNGARY is India's largest enalapril export destination, absorbing 83.4% of total exports worth $196.1M. The top 5 importing countries — HUNGARY, SOUTH AFRICA, MALTA, CROATIA, ECUADOR — together account for 91.8% of India's total enalapril export value. The remaining 110 destination countries collectively receive the other 8.2%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Enalapril to India?

16 origin countries · Total import value: $811.3K

India imports enalapril from 16 countries with a combined import value of $811.3K. The largest supplier is MALTA ($658.8K, 14 shipments), followed by UNITED STATES and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Enalapril to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	MALTA	$658.8K	14	81.2%
2	UNITED STATES	$80.8K	14	10.0%
3	GERMANY	$55.7K	14	6.9%
4	HUNGARY	$4.4K	5	0.5%
5	MALAYSIA	$3.3K	2	0.4%
6	BULGARIA	$3.2K	5	0.4%
7	NETHERLANDS	$1.6K	1	0.2%
8	GUYANA	$1.0K	2	0.1%
9	FRANCE	$842	3	0.1%
10	CANADA	$492	13	0.1%

Showing top 10 of 16 origin countries

MALTA is the largest supplier of enalapril to India, accounting for 81.2% of total import value. The top 5 origin countries — MALTA, UNITED STATES, GERMANY, HUNGARY, MALAYSIA — together supply 99.0% of India's enalapril imports. Click any country to see detailed supplier and buyer data for that import corridor.

Enalapril — Export Intelligence Video

Visual overview of India's enalapril import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's enalapril pharmaceutical import and export market — $235.3M in total trade, 261 verified manufacturers, and 115 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Enalapril

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Enalapril is approved for therapeutic use, with numerous Abbreviated New Drug Applications (ANDAs) listed in the FDA's Orange Book. These approvals facilitate the marketing of generic versions, ensuring broad accessibility. As of March 2026, there are no active FDA import alerts specifically targeting Enalapril or its Indian manufacturers, indicating compliance with U.S. regulatory standards. However, the FDA maintains import alerts for various products and manufacturers, emphasizing the importance of ongoing vigilance to ensure adherence to quality and safety standards.

2EU & UK Regulatory Framework

Within the European Union, Enalapril has been authorized for use in treating hypertension and heart failure. The European Medicines Agency (EMA) has approved products containing Enalapril, such as Aqumeldi, which received marketing authorization on November 15, 2023. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, ensuring that Enalapril products meet stringent safety and efficacy criteria. Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers exporting to these markets, underscoring the necessity for rigorous quality control measures.

3WHO Essential Medicines & Global Standards

Enalapril is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its importance in global health. This inclusion underscores the drug's critical role in treating cardiovascular conditions worldwide. Enalapril formulations are standardized across major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality and efficacy across different regions.

4India Regulatory Classification

In India, Enalapril is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing to ensure affordability. Manufacturers intending to export Enalapril must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national export regulations.

5Patent & Exclusivity Status

The primary patents for Enalapril have expired, leading to a competitive generic market. This has resulted in increased production and export activities, with India emerging as a key supplier of generic Enalapril to various international markets.

6Recent Industry Developments

In November 2023, the EMA granted marketing authorization for Aqumeldi, an Enalapril-containing product, expanding treatment options for heart failure within the EU. (ema.europa.eu) Additionally, in October 2024, the FDA updated Import Alert 66-66, focusing on active pharmaceutical ingredients (APIs) that appear to be misbranded due to labeling issues. While this alert does not specifically target Enalapril, it underscores the FDA's commitment to ensuring proper labeling and compliance among imported pharmaceuticals.

These developments reflect the dynamic nature of the pharmaceutical regulatory landscape, emphasizing the need for continuous monitoring and adherence to international standards to maintain market access and ensure patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Enalapril

Retail & reference prices across 9 markets vs. India FOB export price of $5.32/unit

Global Price Benchmark for Enalapril across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA's Orange Book, enalapril is available in generic formulations, contributing to its affordability.
United Kingdom	$0.11	GBP	The NHS Drug Tariff lists enalapril as a commonly prescribed medication, with prices regulated to ensure cost-effectiveness.
Germany	$0.10	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) oversees the pricing and availability of enalapril in Germany.
Australia	$0.11

Supply Chain Risk Assessment — Enalapril

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned for its generic drug production, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of these critical components are sourced from Chinese manufacturers, underscoring a significant dependency. This reliance is particularly pertinent for drugs like Enalapril, where the synthesis of its API is contingent upon specific KSMs predominantly produced in China.

The concentration of KSM production in China poses a strategic risk. Disruptions in Chinese supply chains, whether due to geopolitical tensions, trade disputes, or internal policy shifts, can lead to substantial shortages and increased costs for Indian pharmaceutical manufacturers. For instance, in September 2020, China increased prices of key starting materials by 10–20%, impacting the cost structures of Indian drug producers. Such events highlight the vulnerability inherent in this supply chain model.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 reveals a pronounced concentration in Enalapril exports from India. The top five exporters account for 91.5% of total export value, with MYLAN LABORATORIES LIMITED alone contributing 83.8% ($197.1 million). This high level of supplier concentration introduces significant single-source risks. Any operational disruptions, regulatory challenges, or quality control issues within these leading firms could severely impact global Enalapril supply.

Access Complete Enalapril Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,403 transactions across 115 markets.

Request Demo View Pricing

Frequently Asked Questions — Enalapril Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top enalapril exporters from India?

The leading enalapril exporters from India are MYLAN LABORATORIES LIMITED, IPCA LABORATORIES LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED, and 12 others. MYLAN LABORATORIES LIMITED leads with 83.8% market share ($197.1M). The top 5 suppliers together control 91.5% of total export value.

What is the total export value of enalapril from India?

The total export value of enalapril from India is $235.3M, recorded across 3,403 shipments from 261 active exporters to 115 countries. The average shipment value is $69.1K.

Which countries import enalapril from India?

India exports enalapril to 115 countries. The top importing countries are HUNGARY (83.4%), SOUTH AFRICA (4.2%), MALTA (1.8%), CROATIA (1.4%), ECUADOR (1.0%), which together account for 91.8% of total export value.

What is the HS code for enalapril exports from India?

The primary HS code for enalapril exports from India is 30049071. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Enalapril

Enalapril

Top Enalapril Exporters from India

Top Countries Importing Enalapril from India

Who Supplies Enalapril to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Enalapril — Export Intelligence Video

Regulatory Landscape — Enalapril

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Enalapril

Supply Chain Risk Assessment — Enalapril

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Enalapril Trade Intelligence

Frequently Asked Questions — Enalapril Exports from India

Who are the top enalapril exporters from India?

What is the total export value of enalapril from India?

Which countries import enalapril from India?

What is the HS code for enalapril exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of enalapril exports from India?

Which ports handle enalapril exports from India?

Why is India a leading exporter of enalapril?

What certifications do Indian enalapril exporters need?

How many buyers import enalapril from India?

What is the market share of the top enalapril exporter from India?

Analysis Methodology